Total Payments
$9,194
2024 Payments
$1,600
Companies
51
Transactions
547
Medicare Patients
4,923
Medicare Billing
$668,188
Payment Breakdown by Category
Food & Beverage$9,086 (98.8%)
Research$61.00 (0.7%)
Education$46.50 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,086 | 542 | 98.8% |
| Unspecified | $61.00 | 1 | 0.7% |
| Education | $46.50 | 4 | 0.5% |
Payments by Type
General
$9,133
546 transactions
Research
$61.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $858.84 | 52 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $830.62 | 60 | $0 (2024) |
| PFIZER INC. | $698.75 | 64 | $0 (2024) |
| Janssen Biotech, Inc. | $615.19 | 46 | $0 (2024) |
| Amgen Inc. | $469.82 | 41 | $0 (2020) |
| Merck Sharp & Dohme LLC | $438.49 | 27 | $0 (2024) |
| Astellas Pharma US Inc | $411.86 | 19 | $0 (2022) |
| GENZYME CORPORATION | $397.52 | 17 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $363.63 | 21 | $0 (2024) |
| Celgene Corporation | $360.75 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,600 | 66 | PFIZER INC. ($264.42) |
| 2023 | $908.36 | 36 | Celgene Corporation ($156.13) |
| 2022 | $699.41 | 25 | Kite Pharma, Inc. ($134.82) |
| 2021 | $122.97 | 6 | Novartis Pharmaceuticals Corporation ($34.96) |
| 2020 | $501.43 | 31 | Janssen Biotech, Inc. ($51.41) |
| 2019 | $2,050 | 129 | Astellas Pharma US Inc ($231.23) |
| 2018 | $2,125 | 151 | E.R. Squibb & Sons, L.L.C. ($486.95) |
| 2017 | $1,187 | 103 | Novartis Pharmaceuticals Corporation ($169.60) |
All Payment Transactions
547 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $26.47 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 12/23/2024 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $30.56 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 12/10/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $56.24 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/09/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: Oncology | ||||||
| 12/07/2024 | Incyte Corporation | — | Food and Beverage | Cash or cash equivalent | $68.63 | General |
| 12/02/2024 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $20.12 | General |
| Category: Hematology | ||||||
| 11/22/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 11/21/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $1.29 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $27.88 | General |
| Category: Oncology | ||||||
| 11/15/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $28.75 | General |
| Category: ONCOLOGY | ||||||
| 11/11/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: Oncology | ||||||
| 11/08/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $0.97 | General |
| Category: ONCOLOGY | ||||||
| 10/28/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: Oncology | ||||||
| 10/25/2024 | GENZYME CORPORATION | CEREZYME (Biological) | Food and Beverage | In-kind items and services | $33.78 | General |
| Category: Genetic Disease | ||||||
| 10/24/2024 | Legend Biotech USA Inc. | — | Food and Beverage | In-kind items and services | $14.84 | General |
| 10/21/2024 | Pharmacosmos Therapeutics Inc. | COSELA (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: HEMATOLOGY | ||||||
| 10/07/2024 | Genentech USA, Inc. | Polivy (Biological) | Food and Beverage | In-kind items and services | $31.71 | General |
| Category: BioOncology | ||||||
| 09/30/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $34.15 | General |
| Category: ONCOLOGY | ||||||
| 09/27/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $29.01 | General |
| Category: Rare Disease | ||||||
| 09/16/2024 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Respiratory | ||||||
| 09/13/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: ONCOLOGY | ||||||
| 09/06/2024 | Genentech USA, Inc. | Venclexta (Biological) | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: BioOncology | ||||||
| 08/30/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $34.04 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular Lymphoma | ABBVIE INC. | $61.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 1,191 | 2,008 | $529,528 | $164,979 |
| 2022 | 7 | 1,151 | 2,129 | $567,564 | $174,072 |
| 2021 | 8 | 1,201 | 2,047 | $540,058 | $170,159 |
| 2020 | 9 | 1,380 | 2,310 | $533,598 | $158,978 |
Total Patients
4,923
Total Services
8,494
Medicare Billing
$668,188
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 85 | 180 | $38,707 | $15,394 | 39.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 146 | 223 | $42,597 | $12,176 | 28.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 64 | 65 | $27,193 | $10,454 | 38.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 89 | 89 | $31,471 | $9,902 | 31.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 47 | 76 | $28,815 | $9,456 | 32.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 107 | 170 | $32,406 | $9,172 | 28.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 76 | 111 | $16,633 | $6,665 | 40.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 45 | 45 | $15,910 | $4,818 | 30.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 21 | 22 | $1,767 | $709.94 | 40.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 324 | 667 | $151,993 | $40,985 | 27.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 126 | 132 | $56,657 | $22,353 | 39.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 176 | 337 | $76,819 | $20,276 | 26.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 95 | 167 | $36,750 | $14,438 | 39.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 74 | 140 | $42,864 | $12,527 | 29.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 179 | 301 | $47,379 | $11,595 | 24.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 94 | 164 | $25,039 | $9,895 | 39.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 87 | 87 | $30,251 | $8,367 | 27.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 93 | 151 | $23,761 | $5,677 | 23.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 42 | 58 | $17,754 | $5,271 | 29.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 49 | 49 | $17,028 | $4,728 | 27.8% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 29 | 45 | $3,771 | $1,467 | 38.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 12 | 12 | $3,531 | $1,399 | 39.6% |
About Dr. Liat Dagan, MD
Dr. Liat Dagan, MD is a Hematology & Oncology healthcare provider based in Boca Raton, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2007. The National Provider Identifier (NPI) number assigned to this provider is 1518167451.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Liat Dagan, MD has received a total of $9,194 in payments from pharmaceutical and medical device companies, with $1,600 received in 2024. These payments were reported across 547 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($9,086).
As a Medicare-enrolled provider, Dagan has provided services to 4,923 Medicare beneficiaries, totaling 8,494 services with total Medicare billing of $668,188. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology, Medical Oncology
- Location Boca Raton, FL
- Active Since 07/19/2007
- Last Updated 02/16/2022
- Taxonomy Code 207RH0003X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1518167451
Products in Payments
- OPDIVO (Biological) $476.48
- KEYTRUDA (Biological) $399.65
- Erleada (Drug) $294.27
- XOSPATA (Drug) $231.23
- EMPLICITI (Biological) $175.04
- JAKAFI (Drug) $171.95
- ELIQUIS (Drug) $167.67
- TIBSOVO (Drug) $165.10
- ADCETRIS (Biological) $165.02
- IMBRUVICA (Drug) $159.98
- LYNPARZA (Drug) $155.85
- Neulasta (Biological) $155.56
- Yescarta (Drug) $146.83
- IBRANCE (Drug) $145.64
- MEKINIST (Drug) $139.51
- PROMACTA (Drug) $137.29
- KISQALI (Drug) $128.94
- Nplate (Biological) $127.47
- Venclexta (Drug) $124.57
- SOMATULINE DEPOT (Drug) $115.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Boca Raton
Mohammad Jahanzeb, Md, MD
Hematology & Oncology — Payments: $1.3M
Hematology & Oncology $1.3M
Dr. Fernando Recio, Md, MD
Hematology & Oncology — Payments: $26,134
Hematology & Oncology $26,134
Dr. Paul Hyman, Md, MD
Hematology & Oncology — Payments: $9,103
Hematology & Oncology $9,103
Dr. Bachir Berbari, Md, MD
Hematology & Oncology — Payments: $6,995
Hematology & Oncology $6,995
Dr. Steven Morris, M.d, M.D
Hematology & Oncology — Payments: $6,937
Hematology & Oncology $6,937
Dr. Aurea Tomeski, M.d, M.D
Hematology & Oncology — Payments: $22.15
Hematology & Oncology $22.15